Literature DB >> 29557911

Preexisting Cancer in Transplant Candidates: Time for a Change in Practice?

Greg A Knoll1,2, Steven J Chadban3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29557911      PMCID： PMC7228613          DOI： 10.1097/TP.0000000000002177

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Recurrence of cancer after renal transplantation.

Authors:  J R Chapman; A G Sheil; A P Disney
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer.

Authors:  Andrea K Viecelli; Wai H Lim; Petra Macaskill; Jeremy R Chapman; Jonathan C Craig; Philip Clayton; Solomon Cohney; Robert Carroll; Germaine Wong
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

4.  The effect of immunosuppression on pre-existing cancers.

Authors:  I Penn
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

5.  Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.

Authors:  Dag Olav Dahle; Tom Grotmol; Torbjørn Leivestad; Anders Hartmann; Karsten Midtvedt; Anna V Reisæter; Geir Mjøen; Hege K Pihlstrøm; Hege Næss; Hallvard Holdaas
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

6.  Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission: A Propensity Score Matched Cohort Study.

Authors:  Sergio A Acuna; Rinku Sutradhar; S Joseph Kim; Nancy N Baxter
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

7.  The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.

Authors:  R A Mukhtar; M L Piper; C Freise; L J Van't Veer; F L Baehner; L J Esserman
Journal:  Am J Transplant       Date:  2016-09-07       Impact factor: 8.086

8.  A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.

Authors:  Laurel A Habel; Steven Shak; Marlena K Jacobs; Angela Capra; Claire Alexander; Mylan Pho; Joffre Baker; Michael Walker; Drew Watson; James Hackett; Noelle T Blick; Deborah Greenberg; Louis Fehrenbacher; Bryan Langholz; Charles P Quesenberry
Journal:  Breast Cancer Res       Date:  2006-05-31       Impact factor: 6.466
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.